Digital Therapeutics and Their Impact on Healthcare, 2019 – Overview of Current Marketed & Pipeline DTx Products Within the 8MM – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Digital Therapeutics and Their Impact on Healthcare” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of current marketed and pipeline DTx products within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China). Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent … [Read more…]

Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Markets, 2017 to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Helicobacter Pylori (H. Pylori) Non-invasive Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global helicobacter pylori (H. Pylori) non-invasive testing market to grow with a CAGR of 4.2% over the forecast period from 2019-2025. The report on … [Read more…]

Global Artificial Joints Market Report 2019: Review, Analysis, Trends, Size, and Forecasts, 2017-2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial Joints Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global artificial joints market to grow with a CAGR of 4.86% over the forecast period from 2019-2025. The report on the global artificial joints market provides qualitative and … [Read more…]

Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX®▼ (daratumumab)

Data supporting the application demonstrated that the investigational subcutaneous formulation improved quality of life, reduced administration time, lowered rates of infusion-related reactions, and was non-inferior compared to intravenous administration1 BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of an extension application to the European Medicines Agency (EMA) for subcutaneous … [Read more…]

Global Intra-abdominal Infections Market Analysis 2017-2019 & Forecast to 2025 – The Excessive Production Capacity of Antimicrobials is Hampering Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Intra-abdominal Infections Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global intra-abdominal infections market to grow with a CAGR of 5.1% over the forecast period from 2019-2025. The report on the global intra-abdominal infections market provides qualitative and … [Read more…]

Global Urology Devices Market Set to Witness a CAGR of 7.2% Over 2019-2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Urology Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global urology devices market to grow with a CAGR of 7.2% over the forecast period from 2019-2025. The report on the global urology devices market provides qualitative and … [Read more…]

Global Bio Surgery Market 2017-2019 & 2025: Drivers, Restraints, Opportunities, Demand Factors, Market Size, Forecasts, and Trends – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Bio Surgery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global bio surgery market to grow with a CAGR of 6.55% over the forecast period from 2019-2025. The report on the global bio surgery market provides qualitative and … [Read more…]

The 2019 Narcolepsy Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts, 2017-2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Narcolepsy Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global narcolepsy treatment market to grow with a CAGR of 7.8% over the forecast period from 2019-2025. The report on the global narcolepsy treatment market provides qualitative and … [Read more…]

Dr. Reddy’s announces the launch of over-the-counter, store-brand equivalent of Allegra-D® 12 HR Allergy and Congestion Extended-Release Tablets (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP, an over-the-counter (OTC) store-brand equivalent of Allegra-D® 12 HR Allergy and Congestion Extended-Release … [Read more…]

Algiax Pharmaceuticals appoints Prof. Claudia Sommer and Dr. Klaus-Dieter Langner to join its Scientific Advisory Board

Clinical neuropathic pain expert Prof. Sommer and long-time pain pharma industry expert Dr. Langner to consult Algiax Pharmaceuticals in the development of AP-325 and further assetts. DÜSSELDORF, Germany–(BUSINESS WIRE)–#koopmans–Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain and other indications with unmet medical need, announced the appointment of … [Read more…]